King Luther Capital Management Corp raised its stake in Zoetis Inc (NYSE:ZTS) by 3.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,302,064 shares of the company’s stock after acquiring an additional 37,900 shares during the quarter. King Luther Capital Management Corp’s holdings in Zoetis were worth $93,801,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in ZTS. Harel Insurance Investments & Financial Services Ltd. acquired a new position in Zoetis in the fourth quarter worth $108,000. Steward Partners Investment Advisory LLC acquired a new position in Zoetis in the third quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in Zoetis by 251.9% in the third quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock worth $121,000 after purchasing an additional 1,360 shares in the last quarter. Shine Investment Advisory Services Inc. boosted its stake in Zoetis by 86.5% in the third quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock worth $143,000 after purchasing an additional 1,040 shares in the last quarter. Finally, Advisory Services Network LLC boosted its stake in Zoetis by 42.4% in the fourth quarter. Advisory Services Network LLC now owns 2,423 shares of the company’s stock worth $175,000 after purchasing an additional 721 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.
In other Zoetis news, insider Roman Trawicki sold 23,885 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $82.00, for a total value of $1,958,570.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Heidi C. Chen sold 37,453 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $81.02, for a total value of $3,034,442.06. The disclosure for this sale can be found here. Insiders have sold 97,001 shares of company stock worth $7,882,428 in the last ninety days. 0.31% of the stock is currently owned by insiders.
Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, February 15th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.03. Zoetis had a return on equity of 65.96% and a net margin of 16.28%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the prior year, the firm posted $0.47 earnings per share. The firm’s revenue for the quarter was up 14.3% compared to the same quarter last year. analysts forecast that Zoetis Inc will post 3.03 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 1st. Stockholders of record on Friday, April 20th will be paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.61%. The ex-dividend date of this dividend is Thursday, April 19th. Zoetis’s dividend payout ratio (DPR) is presently 28.57%.
A number of equities analysts have commented on the company. BMO Capital Markets set a $78.00 price objective on Zoetis and gave the stock a “hold” rating in a research note on Thursday, February 15th. Piper Jaffray Companies set a $88.00 price objective on Zoetis and gave the stock a “buy” rating in a research note on Friday, February 16th. Deutsche Bank boosted their price objective on Zoetis from $76.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, February 16th. UBS Group reissued a “neutral” rating on shares of Zoetis in a research note on Friday, November 24th. Finally, BidaskClub raised Zoetis from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $79.83.
TRADEMARK VIOLATION WARNING: This report was published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3224018/king-luther-capital-management-corp-has-93-80-million-holdings-in-zoetis-inc-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.